These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25475340)

  • 1. Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.
    Cunha KS; Rozza-de-Menezes RE; Andrade RM; Theos A; Luiz RR; Korf B; Geller M
    Orphanet J Rare Dis; 2014 Dec; 9():202. PubMed ID: 25475340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermoscopy of cutaneous neurofibromas associated with neurofibromatosis type 1.
    Duman N; Elmas M
    J Am Acad Dermatol; 2015 Sep; 73(3):529-31. PubMed ID: 26282805
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature.
    Rozza-de-Menezes RE; Brum CAI; Gaglionone NC; de Sousa Almeida LM; Andrade-Losso RM; Paiva BVB; Faveret PLS; da Silva AV; Siqueira OHK; Riccardi VM; Cunha KS
    J Cutan Pathol; 2018 Oct; 45(10):743-753. PubMed ID: 29959804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1.
    Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
    J Dermatol; 2018 Jan; 45(1):53-57. PubMed ID: 28891076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.
    Chilibeck CM; Shah S; Russell HC; Vincent AL
    Ophthalmic Genet; 2021 Jun; 42(3):223-229. PubMed ID: 33594930
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.
    Dance B; Dardare A; Fleming J; Siow SF; Schlub TE; Crawford H; Saunderson RB; Wong C; Berman Y
    J Dermatol; 2024 Aug; 51(8):1050-1059. PubMed ID: 38923593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.
    Thalheimer RD; Merker VL; Ly KI; Champlain A; Sawaya J; Askenazi NL; Herr HP; Da JLW; Jordan JT; Muzikansky A; Pearce EM; Sakamoto FH; Blakeley JO; Anderson RR; Plotkin SR;
    Neurology; 2021 Aug; 97(7 Suppl 1):S32-S41. PubMed ID: 34230197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
    Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
    Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients.
    Duong TA; Bastuji-Garin S; Valeyrie-Allanore L; Sbidian E; Ferkal S; Wolkenstein P
    Dermatology; 2011; 222(3):269-73. PubMed ID: 21540571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
    Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
    Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous neurofibromas: Current clinical and pathologic issues.
    Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
    Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous Upper Intestinal Neurofibromas and Duodenal Periampullary Well-Differentiated Neuroendocrine Tumor Associated With Neurofibromatosis 1.
    Balmer JC; Mikhaylov Y; Lewin DN; Mahvi DM; Ramsay Camp E
    Am Surg; 2021 Jan; 87(1):128-130. PubMed ID: 32856931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
    Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
    Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the distribution of dermal neurofibromas in neurofibromatosis type 1 (NF1) related to the pattern of the skin surface temperature?
    Kaufmann D; Tinschert S; Algermissen B
    Eur J Dermatol; 2001; 11(6):521-6. PubMed ID: 11701400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large number of cutaneous neurofibromas beyond age-appropriate incidence in a patient with a large deletion of NF1.
    Yoshida Y; Ehara Y; Kosaki K; Yamamoto O
    J Dermatol; 2018 Mar; 45(3):363-364. PubMed ID: 29498099
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
    Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
    Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
    PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas.
    Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S
    Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.